Calliditas Therapeutics’ 2019 Annual Report published
Calliditas Therapeutics AB (Nasdaq Stockholm: CALTX) today announces that the Annual Report for 2019 now is available at the company’s website: www.calliditas.com.This information is information that Calliditas Therapeutics AB is obliged to make public pursuant to the Securities Markets Act. The information was submitted for publication at 10:00 CET on April 28, 2020. For further information, please contact: Mikael Widell, Head of Communications Email: mikael.widell@calliditas.com Telephone: +46 703 11 99 60 About Calliditas Calliditas Therapeutics is a specialty